Allspring Global Investments’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $881K | Sell |
24,548
-537,176
| -96% | -$19.3M | ﹤0.01% | 1195 |
|
2025
Q1 | $17.5M | Buy |
561,724
+21,729
| +4% | +$677K | 0.03% | 559 |
|
2024
Q4 | $13.9M | Buy |
539,995
+406,123
| +303% | +$10.5M | 0.02% | 648 |
|
2024
Q3 | $3.79M | Sell |
133,872
-176,980
| -57% | -$5.01M | 0.01% | 1024 |
|
2024
Q2 | $8.2M | Buy |
310,852
+308,102
| +11,204% | +$8.12M | 0.01% | 822 |
|
2024
Q1 | $83.5K | Buy |
2,750
+2,688
| +4,335% | +$81.6K | ﹤0.01% | 1871 |
|
2023
Q4 | $1.74K | Buy |
62
+2
| +3% | +$56 | ﹤0.01% | 2104 |
|
2023
Q3 | $1.63K | Buy |
60
+18
| +43% | +$488 | ﹤0.01% | 2714 |
|
2023
Q2 | $1.29K | Sell |
42
-4,275
| -99% | -$131K | ﹤0.01% | 2647 |
|
2023
Q1 | $156K | Sell |
4,317
-663,013
| -99% | -$23.9M | ﹤0.01% | 1885 |
|
2022
Q4 | $26.4M | Sell |
667,330
-588,474
| -47% | -$23.3M | 0.05% | 496 |
|
2022
Q3 | $50.5M | Buy |
1,255,804
+361,969
| +40% | +$14.5M | 0.09% | 295 |
|
2022
Q2 | $37.6M | Buy |
893,835
+877,718
| +5,446% | +$36.9M | 0.06% | 394 |
|
2022
Q1 | $627K | Sell |
16,117
-10,039
| -38% | -$391K | ﹤0.01% | 2126 |
|
2021
Q4 | $1.04M | Buy |
+26,156
| New | +$1.04M | ﹤0.01% | 1910 |
|